Cáncer colorrectal: Revisión con enfoque en la localización tumoral
Ósmosis Revista Médica Estudiantil · 2022
DOI: 10.32870/orm.vi1.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ósmosis Revista Médica Estudiantil, 2022. Verfasst von Iván Jesús De la Cruz-Vázquez und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third malignant neoplasm with the highest incidence in Mexico and it represents the second cause of cancer death worldwide. The main symptoms are changes in bowel habits, rectal bleeding, and rectal mass; these can vary depending on the tumor location and the current disease stage when the diagnosis is made. The survival rate for localized CRC is 90%, 68% if regional lymph nodes are affected, and 10% if a distant metastases is present, usually in the liver. The gold standard is the histopathological study of biopsy. Based on the available evidence, it is important to acknowledge and implement the CRC screening plans for reducing morbidity and mortality.
Zitieren
APA
Cruz-Vázquez, I. J. D. L., & Lara-Valadez, M. G. (2022). Cáncer colorrectal: Revisión con enfoque en la localización tumoral. Ósmosis Revista Médica Estudiantil. https://doi.org/10.32870/orm.vi1.7
Vancouver
Cruz-Vázquez IJDL, Lara-Valadez MG. Cáncer colorrectal: Revisión con enfoque en la localización tumoral. Ósmosis Revista Médica Estudiantil. 2022. doi:10.32870/orm.vi1.7
BibTeX
@article{CruzVzquez2022,
author = {Cruz-Vázquez, Iván Jesús De la and Lara-Valadez, Melissa Guadalupe},
title = {Cáncer colorrectal: Revisión con enfoque en la localización tumoral},
journal = {Ósmosis Revista Médica Estudiantil},
year = {2022},
doi = {10.32870/orm.vi1.7}
}
EUVIMED